HPM Partners »

Avita Therapeutics shares owned by HPM Partners

Quarter-by-quarter ownership of Avita Therapeutics (RCEL) shares owned by HPM Partners from 13F filings

Historical chart of HPM Partners investment in Avita Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Avita Therapeutics held by HPM Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Avita Therapeutics by HPM Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $53k 13k 4.13

More positions owned by HPM Partners

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Ishares Tr Core S&p500 Etf (IVV)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Microsoft Corporation (MSFT)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Amazon (AMZN)
Broadcom (AVGO)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Core Us Aggbd Et (AGG)
Procter & Gamble Company (PG)
Eli Lilly & Co. (LLY)

View all positions for HPM Partners

Top funds holding Avita Therapeutics

Vanguard Capital Management
BlackRock
State Street Corporation
Geode Capital Management
Marshall Wace
AQR Capital Management
Vanguard Fiduciary Trust
Morgan Stanley
Goss Wealth Management
Macquarie Group
Quantinno Capital Management
Divisadero Street Capital Management
UBS Group
Goldman Sachs Group
Northern Trust

View all funds holding Avita Therapeutics